BillionToOne stock sinks 16% ahead of March earnings: what traders are watching
BillionToOne shares fell 15.7% to $72.10 in Monday’s session, outpacing declines in major indexes. The diagnostics firm, newly public, is set to report fourth-quarter and full-year results on March 4. Investors are watching for signs of demand and margins as the company expands in prenatal and oncology testing. No new company updates have been issued since February 17.